Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PAR4 inhibitor therapy for patients with PAR4 polymorphism

PAR4 inhibitor therapy for patients with PAR4 polymorphism

US Patent 9789087 · Granted Oct 17, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of platelet function and methods for use of the same2025
Functional and therapeutic effects of PAR4 cleavage by cathepsin G2024
Inhibitors of platelet function and methods for use of the same2022
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and2022
Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the s2022
Hydroxyeicosatrienoic acid compounds and their use as therapeutic agents2021
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and2020
Non-selective protease activated receptor 4 ALA120THR isoform antagonist2020
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and2019
Methods of prevention or treatment for pathologic thrombosis or inflammation2017
Methods of prevention or treatment for pathologic thrombosis or inflammation2017
Use of platelet polymorphism P1A2 to diagnose risk of thrombotic disease1999